GL1X · GenesisL1 explorer

MolNFT v1 · #149264 · protein

Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-007

6FV9: “Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-007”. X-ray diffraction, 3 ligands (E8H, MG, ZN). MolNFT v1 #149264 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6FV9
Type
protein
Length
665 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q8WQX9
Ligands
E8H, MG, ZN

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein333—Q8WQX9
B—protein332—Q8WQX9

Ligands and binding sites

  • E8H · 1-(2-{4-[(4as,8ar)-4-(3,4-dimethoxyphenyl)-1-oxo-1,2, 4A,5,8,8A-hexahydrophthalazin-2-yl]piperidin-1-yl}-2-oxoethyl)pyrrolidine-2,5-dione · ligand · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • GOL · Glycerol · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6FV9 · Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-007 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.